nohealthproblemsnews.com
Home » SARS-CoV-2 »
Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody […] The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is primarily a respiratory […] COVID-19 needs no introduction. Last year, the disease, which is caused by the virus SARS-CoV-2, reached every continent across the […] Two MIT professors have proposed a new approach to estimating the risks of exposure to Covid-19 under different indoor settings. […] A new study, released on the medRxiv* preprint server, indicates that the spread of the coronavirus disease 2019 (COVID-19) is […] The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has proved to be […] Amid the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), scientists aim to determine ways […] University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-CoV-2-;the virus that causes […] The causative agent of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, […] The emergence of a novel human coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first detected in Wuhan, […]
FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19
SARS-CoV-2 can alter bone marrow macrophage (BMM)-to-osteoclast differentiation, study finds
Triangular-shaped spikes aid the success of coronavirus transmission
A new approach to estimate the risks of exposure to COVID-19 under different indoor settings
Allometric model shows human travel is closely related to spread of COVID-19
ACE2 homology in laboratory and wild animals
Monitoring CO2 to assess risk of indoor airborne SARS-CoV-2 transmission
FDA-approved cancer drug blunts SARS-CoV-2 protein's detrimental effects
Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay
Researchers develop new rapid and highly sensitive SAR-CoV-2 RNA detection test
